Stay updated on Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Melanoma Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T03:56:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide notice about NIH’s terminology transition appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-27T06:41:34.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T06:59:15.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-10-13T08:16:57.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, replacing the expected content. The change reflects an access issue rather than a real update to the study information on the page.
    Difference
    18%
    Check dated 2026-09-22T06:41:21.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study locations list was updated to add Tel Litwinsky, Israel, 52621 and remove Qiryat Krinitzi, Israel, 52621.
    Difference
    0.0%
    Check dated 2026-09-15T01:52:56.000Z thumbnail image

Stay in the know with updates to Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Melanoma Immunotherapy Clinical Trial page.